The Connection Between Vitamin B3 (Niacin) Deficiency and Chronic Fatigue

Being fatigued is one of the most common, yet least specific, complaints in medicine. There are so many factors that can cause it, such as sleep problems, endocrine conditions, mental health disorders, infections, medications, or deconditioning due to inactivity [1-3].

A less obvious, but biologically important contributor to chronic, low-grade fatigue is a vitamin B3 (niacin) deficiency. Niacin is the dietary precursor of nicotinamide adenine dinucleotide (NAD⁺), a coenzyme that is fundamental to metabolism [4,5]. NAD⁺ is involved in the regulation of cellular metabolism and plays roles in energy production, DNA repair, mitophagy and autophagy, inflammation, and neuronal function [5].

When niacin (or tryptophan, which the body can convert into niacin in the liver) is insufficient, the downstream shortfall in NAD⁺ can impair the production of ATP in the mitochondria, the cellular energy factories, and alter neurotransmitter pathways (dopamine and serotonin) in the brain [6]. In its extreme form, niacin deficiency presents as pellagra, whereas in milder or secondary forms, it may contribute to chronic fatigue syndromes or fatigue symptoms.

The goals of this article are to unravel the connection between niacin deficiency and the role it can play in chronic fatigue.

What is Vitamin B3 (Niacin) and Why Does It Matter?

Vitamin B3 refers to nicotinic acid (niacin) and nicotinamide (niacinamide) [7]. Both act as precursors for NAD⁺ and NADP⁺, two central cofactors in hundreds of enzymatic reactions that take place within the body. NAD⁺ is essential for efficient cellular energy production – when its availability drops, mitochondrial respiration is impaired and cells struggle to sustain ATP production, which can manifest clinically as low energy, weakness, and cognitive slowing. Long-term niacin deficiency is associated with loss of memory and depression, symptoms that are resolved or blunted when niacin is provided [8,9].

How is Niacin Deficiency Linked to Chronic Fatigue?

NAD⁺ is a fundamental enzyme in ATP production, and when chronically reduced, it can lower ATP output in the mitochondria, increase oxidative stress, and impair muscle and brain function. These mechanisms, perhaps unsurprisingly, can produce tiredness, reduced exercise tolerance, and cognitive impairment [9].

Tryptophan is an essential amino acid that serves as a precursor for both serotonin, an important neurotransmitter, and niacin itself [10]. When tryptophan is diverted down the kynurenine pathway (in settings of chronic inflammation or infection, for instance), there is less available to make these important molecules.

Beyond energy generation, NAD⁺ is a substrate for sirtuins and other enzymes involved in mitochondrial biogenesis, stress responses, and the repair of DNA [11,12]. Chronic NAD⁺ depletion can impair adaptive cellular responses to stress, which might offer a plausible route towards persistent malaise, poor recovery, and fatigue under conditions of physiological stress. 

What Does the Clinical Evidence Say?

There is a lack of large, randomized clinical trials linking dietary niacin deficiency to chronic fatigue syndrome, which might be partly because severe deficiency is rare in high-income countries due to sufficient dietary intake and the presence of fortified foods [13].

Historical and clinical research literature links pellagra (severe niacin deficiency) to overwhelming fatigue and reversible neurocognitive symptoms that are rapidly improved following niacin treatment [8,9].

Although mechanistic data are strong, human clinical evidence is suggestive but not definitive, especially for mild, subclinical niacin shortfalls in otherwise well-nourished populations.

Who is at Risk for Niacin Deficiency-Related Chronic Fatigue?

The populations and situations that might lead to niacin or tryptophan shortfall include diets that are very low in these nutrients, chronic alcoholism [14], malabsorptive gastrointestinal disease, certain drugs, genetic conditions (e.g., Hartnup disease causes impaired tryptophan absorption) [15,16], and chronic inflammation (via shunting tryptophan to kynurenine) [17].

Lifestyle Factors

Foods that are rich in niacin and tryptophan (e.g., meat, poultry, fish, eggs, dairy, legumes, nuts, and fortified grains) can help prevent deficiency.

Niacin is found in a wide range of food items. Many animal-based foods, including poultry, beef, and fish, provide around 5-10 mg of niacin per serving, primarily in the highly bioavailable forms NAD and NADP, according to the National Institutes of Health. Plant-based foods provide around half this amount per serving, mainly as nicotinic acid. Many breads, cereals, and infant formulas in the United States and elsewhere are fortified with this important vitamin in its free form, which is highly bioavailable.  

Tryptophan is another indirect food source of niacin because this amino acid can be converted to NAD. Again, according to the National Institutes of Health, the most commonly used estimate of efficiency for tryptophan conversion to NAD is 1:60 (1 mg niacin obtained from 60 mg tryptophan). However, the efficiency of tryptophan conversion to NAD varies considerably in different people.

Safety Considerations for Niacin

Niacin at high pharmacologic doses can cause flushing, gastrointestinal upset, liver toxicity (rare at very high doses), and other adverse effects [18,19]. Before engaging in any supplementation regimen, the advice of a qualified physician should be sought. No adverse effects have been reported from the consumption of naturally occurring niacin in foods, only in settings of dietary supplements or medications [20,21].

Conclusion

Niacin (vitamin B3) is biochemically central to cellular energy generation because it forms NAD⁺, which is a key cofactor for ATP production in the cell. Low niacin could lead to impaired energy generation through lower NAD⁺, but this could be an oversimplified pathway to fatigue.

Severe deficiency, termed pellagra, clearly causes profound fatigue and cognitive dysfunction but can be rapidly treated with niacin provision. Milder or secondary niacin/NAD⁺ deficits may contribute to chronic fatigue in at-risk groups, but the evidence is limited in high-income countries due to fortification and dietary abundance.

If fatigue is chronic and unexplained, people should consult their physician, who will likely screen for nutritional and metabolic contributors, particularly in people with poor diet, alcoholism, malabsorption, certain medications, or chronic inflammation.

If you're a practitioner interested in all things niacin, take a look at Tro+ Calm, our practitioner-only, extra-strength, and next-generation formulation designed to help patients relieve stress, reduce anxiousness, and quiet the mind when they need it most.

If you're interested in reading more about niacin, check out these blog articles:

• Niacin vs. Niacinamide: Understanding Vitamin B3, Benefits, and Side Effects
• Does Vitamin B3 Increase Testosterone?
• Does Vitamin B3 Help Hair Growth?
• The Difference Between “Flush” and “No-Flush” Niacin
• Does niacin cross the blood-brain barrier?

References

[1]         N. Noor, I. Urits, A. Degueure, L. Rando, V. Kata, E.M. Cornett, A.D. Kaye, F. Imani, M. Narimani-Zamanabadi, G. Varrassi, O. Viswanath, A Comprehensive Update of the Current Understanding of Chronic Fatigue Syndrome, Anesth Pain Med 11 (2021). https://doi.org/10.5812/aapm.113629.

[2]         W.J. Evans, C.P. Lambert, Physiological Basis of Fatigue, American Journal of Physical Medicine & Rehabilitation 86 (2007) S29–S46. https://doi.org/10.1097/PHM.0b013e31802ba53c.

[3]         G.C. Bogdanis, Effects of Physical Activity and Inactivity on Muscle Fatigue, Front. Physio. 3 (2012). https://doi.org/10.3389/fphys.2012.00142.

[4]         A.J. Covarrubias, R. Perrone, A. Grozio, E. Verdin, NAD+ metabolism and its roles in cellular processes during ageing, Nat Rev Mol Cell Biol 22 (2021) 119–141. https://doi.org/10.1038/s41580-020-00313-x.

[5]         S. Lautrup, Y. Hou, E.F. Fang, V.A. Bohr, Roles of NAD⁺ in Health and Aging, Cold Spring Harb Perspect Med 14 (2024) a041193. https://doi.org/10.1101/cshperspect.a041193.

[6]         V. Gasperi, M. Sibilano, I. Savini, M.V. Catani, Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications, IJMS 20 (2019) 974. https://doi.org/10.3390/ijms20040974.

[7]         T.D. Spies, THE TREATMENT OF SUBCLINICAL AND CLASSIC PELLAGRA: USE OF NICOTINIC ACID, NICOTINIC ACID AMIDE AND SODIUM NICOTINATE, WITH SPECIAL REFERENCE TO THE VASODILATOR ACTION AND THE EFFECT ON MENTAL SYMPTOMS, JAMA 111 (1938) 584. https://doi.org/10.1001/jama.1938.02790330004002.

[8]         A.-L. Tardy, E. Pouteau, D. Marquez, C. Yilmaz, A. Scholey, Vitamins and Minerals for Energy, Fatigue and Cognition: A Narrative Review of the Biochemical and Clinical Evidence, Nutrients 12 (2020) 228. https://doi.org/10.3390/nu12010228.

[9]         G. Rennie, A.C. Chen, H. Dhillon, J. Vardy, D.L. Damian, Nicotinamide and neurocognitive function, Nutritional Neuroscience 18 (2015) 193–200. https://doi.org/10.1179/1476830514Y.0000000112.

[10]       T. Fukuwatari, K. Shibata, Nutritional Aspect of Tryptophan Metabolism, Int J Tryptophan Res 6s1 (2013) IJTR.S11588. https://doi.org/10.4137/IJTR.S11588.

[11]       S. Imai, L. Guarente, NAD+ and sirtuins in aging and disease, Trends in Cell Biology 24 (2014) 464–471. https://doi.org/10.1016/j.tcb.2014.04.002.

[12]       N. Xie, L. Zhang, W. Gao, C. Huang, P.E. Huber, X. Zhou, C. Li, G. Shen, B. Zou, NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential, Sig Transduct Target Ther 5 (2020) 227. https://doi.org/10.1038/s41392-020-00311-7.

[13]       Effectiveness of food fortification in the United States: the case of pellagra, Am J Public Health 90 (2000) 727–738. https://doi.org/10.2105/AJPH.90.5.727.

[14]       A. Rao, S. Garg, V. Gaurav, Pellagra in chronic alcoholism: An underdiagnosed condition in modern clinical practice, Journal of the Royal College of Physicians of Edinburgh 54 (2024) 332–334. https://doi.org/10.1177/14782715241298723.

[15]       A. Patel, A. Prabhu, Hartnup disease, Indian J Dermatol 53 (2008) 31. https://doi.org/10.4103/0019-5154.39740.

[16]       H.F. Seow, S. Bröer, A. Bröer, C.G. Bailey, S.J. Potter, J.A. Cavanaugh, J.E.J. Rasko, Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19, Nat Genet 36 (2004) 1003–1007. https://doi.org/10.1038/ng1406.

[17]       M. Dehhaghi, H.K.S. Panahi, B. Kavyani, B. Heng, V. Tan, N. Braidy, G.J. Guillemin, The Role of Kynurenine Pathway and NAD⁺ Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Aging and Disease 13 (2022) 698. https://doi.org/10.14336/AD.2021.0824.

[18]       S.L. Young, G. Gazzard, The adverse effects of oral niacin/nicotinamide - an overview of reviews, Eye 39 (2025) 2852–2859. https://doi.org/10.1038/s41433-025-04027-2.

[19]       C. Minto, M.G. Vecchio, M. Lamprecht, D. Gregori, Definition of a tolerable upper intake level of niacin: a systematic review and meta-analysis of the dose-dependent effects of nicotinamide and nicotinic acid supplementation, Nutrition Reviews 75 (2017) 471–490. https://doi.org/10.1093/nutrit/nux011.

[20]       M.A. Ellsworth, K.R. Anderson, D.J. Hall, D.K. Freese, R.M. Lloyd, Acute Liver Failure Secondary to Niacin Toxicity, Case Reports in Pediatrics 2014 (2014) 1–3. https://doi.org/10.1155/2014/692530.

[21]       M.K. Mittal, T. Florin, J. Perrone, J.H. Delgado, K.C. Osterhoudt, Toxicity From the Use of Niacin to Beat Urine Drug Screening, Annals of Emergency Medicine 50 (2007) 587–590. https://doi.org/10.1016/j.annemergmed.2007.01.014.